Skip to main content
. Author manuscript; available in PMC: 2012 Feb 1.
Published in final edited form as: Am J Cardiol. 2011 Feb 1;107(3):406–411. doi: 10.1016/j.amjcard.2010.09.035

Table 2.

Spearman Correlations of HOMA IR and Apolipoprotein B with Lipid, Metabolic and Inflammatory variables

Diabetes Mellitus
Variable Yes (N=611) No (N=803)
HOMAIR Apo-B HOMAIR Apo-B
Total cholesterol 0.03 0.77** 0.07* 0.77**
Triglycerides 0.38** 0.47** 0.39** 0.50**
LDL cholesterol -0.01 0.79** 0.10** 0.78**
HDL cholesterol -0.31** -0.21** -0.32** -0.20**
Non HDL cholesterol 0.16** 0.87** 0.22** 0.87**
Systolic Blood pressure 0.14** 0.05 0.32** 0.20**
Body Mass Index 0.43** 0.07 0.50** 0.23**
Waist (inches) 0.41** 0.08* 0.51** 0.25**
Framingham risk 0.06 0.38** 0.27** 0.49**
Hs C reactive protein 0.22** 0.16** 0.29** 0.24**
Interleukin-6 0.26** 0.02 0.30** 0.12**
Leptin 0.42** 0.03 0.34** 0.18**
Adiponectin -0.28** -0.20** -0.27** -0.15**
ApoB 0.20** - 0.25** -
HOMA IR - 0.20** - 0.25**

HOMA-IR = homeostasis model assessment of insulin resistance; for type 2 diabetic subjects, N=513; subjects on insulin excluded. HDL= High density Lipoprotein; LDL = Low density lipoprotein; CRP = C reactive protein.

*

P<0.05

**

P<0.01